search
triResolve
benefits
how it works
inside triResolve
getting started
triResolve QuickPort
regulation
triReduce
triBalance
Webinars
home > services > triResolve > regulation
triResolve - portfolio reconciliation & counterparty exposure management service
Regulatory update

Portfolio reconciliation regulation

Regulatory agencies around the globe are publishing new regulations for portfolio reconciliation of OTC derivatives portfolios. Recently the CFTC in the US and ESMA in Europe have issued their guidelines.  TriOptima’s award-winning service, triResolve, assists market participants in meeting those guidelines. With over 250 firms using triResolve, it is the market leader offering a network community platform that includes all major counterparties.

TriOptima is hosting a series of regional roundtables on the outlined CFTC and EMIR regulations. Click here to find out when and where the next one will take place.

We have also summarized the new European and U.S. regulations below as a general framework but implementation should be guided by each institution’s compliance and legal teams.

United States – CFTC Rules
The CFTC published the final rules pertaining to portfolio reconciliation in the Federal Register on September 11, 2012. They are described in Sect. 23.502 of 17 CFR Part 23  “Confirmation, Portfolio Reconciliation, Portfolio Compression, and Swap Trading Relationship Documentation Requirements for Swap Dealers and Major Swap Participants”; Final Rule, and can be accessed directly on the CFTC website.

A summary of the final rules is presented below. triResolve assists subscribers in meeting the standards by providing key functionality for reconciliation, exception resolution workflow and reporting analytics.

United States - summary of the new CFTC rules relating to portfolio reconciliation
 click on image to enlarge

Europe – ESMA Rules
On 27 September 2012, ESMA issued its Draft Technical Standards Final Report which put forward a number of suggested  rules for  the European  OTC derivatives market, including a section on compulsory portfolio reconciliation and dispute resolution processes. The European Parliament adopted the standards without objection after which they were published in the European Union’s Official Journal on 23 February 2013. Once they enter into force on 15 March 2013, participants will have until 15 September 2013 before they have to be fully compliant with the portfolio reconciliation and dispute resolution requirements. 

Below is a summary of the rules relating to portfolio reconciliation and dispute resolution.

Europe – summary of the new ESMA rules relating to portfolio reconciliation

 click on image to enlarge

 

This summary presents TriOptima’s understanding of the rules, is for informational purposes only and is not intended to be comprehensive. TriOptima does not warrant its accuracy or completeness and TriOptima and its affiliates accept no liability whatsoever for any use of this information or any action taken based on or arising from the information. This summary does not constitute a recommendation to take any action, and TriOptima is not providing and does not intend to provide any legal or regulatory advice. You should consult with your counsel for any legal or regulatory advice regarding this information as it may apply in your circumstances.




downloads icon
Downloads

 REGULATION 
 TRIRESOLVE 

 REGULATION 
 TRIRESOLVE 

 ARTICLE 
 TRIRESOLVE 
Reconciliation: Key to controlling OTC derivative exposures for the buy side
Insight providers: Mary Harris, Business Manager triResolve and Susan Hinko, Head of Industry Relations, TriOptima The new year brings with it an onslaught of requirements for managing OTC derivative portfolios, cleared an

 INSIGHT 
 TRIRESOLVE 
time
New York office
+1 646 744 0400		 time
London office
+44 20 7382 2200		 time
Stockholm office
+46 8 545 25 130		 time
Singapore office
+65 6372 8181
time
Tokyo office
+81 3 6450 1350
 TriOptima logo
 
 triResolve portfolio reconciliation & counterparty exposure management | triReduce portfolio compression & early termination | triBalance counterparty risk rebalancing

© 2004-2013 TriOptima AB, an ICAP Group Company. All rights reserved | Terms of use | Privacy statement | Site map | Info security | Site build
Please enter your full name.

Disclaimer
Interest Rate Trade Reporting Repository
Terms and Conditions for Access and Use


1. Scope of Agreement
    These terms and conditions (this "Agreement") govern your access to and use of any public repository reports of OTC interest rate derivatives (each a "Report") produced by TriOptima AB ("TriOptima"), as described on the information web page regarding the repository. You must accept this Agreement to access and use Reports. You accept the Agreement by clicking the "I Agree" button on the bottom of this page. TriOptima may at any time, without advance or specific notice, amend this Agreement. Hence, you are expected to review and accept this Agreement each time you wish to access any Report through this website.


2. Intellectual property rights, license to use
    You acknowledge that TriOptima is the sole and exclusive owner of any and all intellectual property rights to the structure and layout of any Report.


    TriOptima hereby grants to you a non-exclusive license to use Reports in accordance with this Agreement.


3. Prohibited use of Reports
    You must not use any Report or the information contained in any Report in a manner that may harm or be detrimental to TriOptima, including without limitation, to use any Report to directly or indirectly compete or promote competition with TriOptima.


    You are not allowed to use TriOptima's name or any trademarks, trade names or service marks contained in any Report or this website in advertising, publicity or otherwise; neither are you allowed to copy any marks, specific characteristics or attributes of any Report for any other purpose than for making a lawful and contractually permitted copy of a Report.


4. Non-reliance, no warranty, disclaimer
    Each Report is provided to you free of charge. However, TriOptima does not warrant or undertake to make any Reports available to you; hence you acknowledge that TriOptima, in its sole discretion, may or may not make Reports available to you via this website or otherwise.


    Each Report is intended for information purposes only. Any information in a Report may at any time be superseded or replaced by new or updated information. Furthermore, the information contained in a Report is based on the information submitted by third parties for the purpose of inclusion in such Report. The information contained in a Report is neither checked, nor verified by TriOptima. Consequently, you acknowledge that Reports are for information purposes only, that they may not be relied upon for any purpose whatsoever, and that they are dependent upon, as regards their accuracy and completeness, the data submitted to TriOptima by third parties.


    The parties acknowledge that TriOptima makes no representation or warranty with respect to any Report or this website or any data or materials retrieved, obtained, provided or transmitted, by or to you, using this website. Each Report and this website and all such data and materials are being provided to you "as is". TriOptima hereby disclaims any and all representations and warranties, whether express or implied, including without limitation, any representation or warranty as to merchantability or fitness for a particular purpose, any representations or warranties arising from course of dealing or course of performance, and any representations or warranties of accuracy, reliability or functionality.


    To the maximum extent permitted by law, TriOptima disclaims all liability arising out of or in connection with the use of any Report or this website.

    Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.


    Notwithstanding anything to the contrary in this Agreement, TriOptima does not exclude or limit its liability for wilful misconduct, fraud or death or personal injury arising from TriOptima's negligence.


    For purposes of this clause, references to TriOptima shall be deemed to include its affiliates and their respective partners, officers, employees, directors, agents, contractors, representatives, successors and assigns.


5. Viruses, malware
    To the best of TriOptima's knowledge, Reports published on this website, this website and the server on which it resides are free from viruses and other malware. However, TriOptima cannot warrant this to be the case, and it is your responsibility to take precautions to prevent your computer and/or network to be affected by viruses or other malware. Hence, TriOptima does not assume any liability for any damage or loss, whether direct or indirect, including loss of data, caused to you by viruses or other malware from Reports published on this website, this website or the server on which it resides, including when you download any Report.


6. Applicable law, disputes
    This Agreement and any non-contractual obligations arising in connection with it shall be governed by English law, without regard to its principles of conflicting laws. Each party submits to the exclusive jurisdiction of the English courts for all purposes relating to this Agreement (including the enforcement of any determinations).
I agree    I decline